Search

everythinglearnresearchcommunity

for

Search:↓

Thorough evaluation is crucial for postmenopausal women with virilization to detect rare ovarian tumors.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Some drugs can reduce male semen quality.

Red ginseng oil improves urinary symptoms and some sexual functions in men safely.

Loestrin effectively normalizes testosterone levels and improves PCOS symptoms with minimal side effects.

Low-dose finasteride may increase erectile dysfunction risk over time.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Low zinc levels are linked to low testosterone but not to sexual problems.

Testosterone and finasteride improve body composition in men with spinal cord injury.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Serenoa repens may cause long-lasting sexual and psychiatric side effects.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.